ProShares Ultra Profile

49.79
USD 0.43  0.86%
14%
7%

ProShares Ultra Summary

ProShares Ultra Nasdaq Biotechnology [BIB] is traded in USA and was established 2010-04-06. The fund is classified under Trading--Leveraged Equity category within ProShares family. ProShares Ultra Nasdaq Biotechnology currently have 305.89 M in assets under management (AUM). , while the total return for the last 3 years was -9.21%.
Check ProShares Ultra Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Top Etf Constituents

ProShares Ultra Target Price Odds Analysis

Odds Below 49.79HorizonTargetOdds Above 49.79
14.88%30 days 49.79 85.02%
Based on normal probability distribution, the odds of ProShares Ultra to move above current price in 30 days from now is about 85.02% (This ProShares Ultra Nasdaq Biotechnology probability density function shows the probability of ProShares Ultra Etf to fall within a particular range of prices over 30 days) .

ProShares Ultra Nasdaq Risk Profiles

ProShares Ultra Nasdaq Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. ProShares Ultra Nasdaq Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ProShares Ultra price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

ProShares Ultra Key Fundamentals

ProShares Ultra Against Markets

ProShares Ultra Current Ratings

ProShares Ultra Nasdaq Biotechnology 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
51 
Equity ratings for ProShares Ultra Nasdaq Biotechnology are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks daily investment results that correspond to two times the daily performance of the Nasdaq Biotechnology Index. ProShares Ultra is traded on NASDAQ General Markets in USA. more
NameProShares Ultra Nasdaq Biotechnology
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerProShares
ExchangeNASDAQ General Markets
Etf FamilyProShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone866 776 5125
CurrencyUSD - US Dollar
IssuerProShares
DescriptionProShares Ultra Nasdaq Biotechnology
Inception Date2010-04-07
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management336.47 Million
Average Trading Valume228,051
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year EndMay 31
ExchangeThe NASDAQ Stock Market LLC
Market MakerVirtu Financial
Total Expense1.04
Management Fee0.75
Nav Price50.15
Two Hundred Day Average60.35
Ytd-10.54%
Average Daily Volume In Three Month118.98k
Fifty Two Week Low48.12
Average Daily Volume Last 10 Day151.81k
Fifty Two Week High70.82
One Month-27.99%
Fifty Day Average63.89
Three Month-21.65%
Beta In Three Year3.41
Check also Trending Equities. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Search macroaxis.com